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Abstract
Background: Left atrial enlargement (LAE) has been proven to be significantly related to stroke and cardiovascular
diseases. In China, few studies related to LAE have been conducted, especially in the general population. To the
best of our knowledge, our study is the first to explore the prevalence of LAE and associated risk factors in the
general Chinese population.
Methods: This study included a total of 11,956 subjects aged ≥35 years. All participants completed a questionnaire,
and underwent complete physical examination, electrocardiogram (ECG) and echocardiogram. We defined LAE as a
LA diameter exceeding 4.0 cm in men and 3.8 cm in women. We conducted a multivariable logistic regression
analysis and a linear regression analysis to identify independent factors of LAE.
Results: The overall prevalence of LAE was 6.43 % for subjects aged over 35 years. The prevalence of LAE was
6.78 % in women and 6.02 % in men. The major risk factors of LAE were female sex (odds ration [OR]: 1.229, β:
0.197), advancing age (OR: 1.015, β: 0.036), high systolic blood pressure (OR: 2.331, β: 0.185), high body mass index
(BMI) (OR: 3.956, β: 0.373), diabetes (OR: 1.498, β: 0.030), high left ventricular myocardial index (OR: 1.003, β: 0.073),
and low left ventricular ejection fraction, low heart rate, and low estimated glomerular filtration rate. Additionally,
the association between BMI and LAE was the most obvious.
Conclusions: Female sex, advancing age, high systolic blood pressure, high BMI, diabetes, high left ventricular
myocardial index, low estimated glomerular filtration rate, low left ventricular ejection fraction, and low heart rate
were proven to be risk factors of LAE.
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Background
Several studies have shown that alterations in the left
ventricular structure and function are associated with an
increased risk of cardiovascular morbid and fatal events
[1–3]. Recently, left atrial enlargement (LAE) has been
proven to be significantly related to stroke and cardio-
vascular diseases [4–7]. Furthermore, some studies have
found that LAE may be a more sensitive indicator of
cardiovascular diseases, compared with left ventricular
remodeling [8, 9]. Therefore, the study of the prevalence
of LAE and its risk factors is becoming increasingly
important. However, very few studies conducted on the
general population have focused on LAE. At present,
almost all of the research is aimed at patients with high
blood pressure (BP), or those who are hospitalized.
Moreover, no research studies on the general Chinese
population have focused on LAE. To the best of our
knowledge, our study is the first to explore the preva-
lence of LAE and its risk factors in the general Chinese
population, including over 10,000 participants. The aims
of our study were as follows: (1) to investigate the preva-
lence of LAE in a rural Chinese population consisting of
a general adult population rather than patients that were
indicated to undergo echocardiographic examination for




From January 2012 to August 2013, a representative
sample of participants aged ≥35 years was selected to
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characterize the prevalence and risk factors in rural
areas of Liaoning Province, located in China. The study
adopted a multi-stage, stratified, random-cluster sam-
pling scheme. In the first stage, three counties (Dawa,
Zhangwu and Liaoyang County) were randomly selected
from Liaoning province. In the second stage, one town
was randomly selected from each county (for a total of
three towns). In the third stage, 8–10 rural villages from
each town were randomly selected (for a total of 26 rural
villages). Participants who were pregnant or had malig-
nant tumors or mental disorders were excluded from the
study, comprising a potential pool of 14,016 people. Of
these, 11,956 participants agreed and completed the
present study, yielding a response rate of 85.3 %. In this
report, we used only the data from participants who
completed the study, which provided a final sample size
of 10,574 subjects (4768 men and 5806 women). For the
present analysis, participants with atrial fibrillation
showed by Electrocardiogram that made diastolic func-
tion and diameter assessment unreliable with conven-
tional Doppler technique were also excluded.
The study was approved by the Ethics Committee of
China Medical University (Shenyang, China). All proce-
dures were performed in accordance with ethical standards.
Written consent was obtained from all participants after
they had been informed of the objectives, benefits, medical
items and confidentiality agreement regarding their per-
sonal information. For participants who were illiterate, we
obtained written informed consent from their proxies.
Data collection and measurements
Data were collected during a single visit to the clinic by
cardiologists and trained nurses using a standard ques-
tionnaire in a face-to-face interview. Before the survey
was performed, we invited all eligible investigators to
attend an organized training session. The training in-
cluded the purpose of this study, how to administer the
questionnaire, the standard method of measurement, the
importance of standardization and the study procedures.
A strict test was administered after this training, and
only those who scored perfectly on the test were accepted
as investigators in this study. During data collection, our
inspectors gave some further instructions and support. Data
regarding the demographic characteristics, lifestyle risk
factors, dietary habits, family income and family history of
chronic diseases were obtained during the interview using
the standardized questionnaire. The study was guided
by a central steering committee with a subcommittee
for quality control.
According to American Heart Association protocol,
BP was measured three times at 2-min intervals after at
least 5 min of rest using a standardized automatic elec-
tronic sphygmomanometer (HEM-907; Omron), which
had been validated according to the British Hypertension
Society protocol [10] . The participants were advised to
avoid caffeinated beverages and exercise for at least
30 min before the measurement. During the measure-
ment, the participants were seated with their arms sup-
ported at the level of the heart. The mean of three BP
measurements was calculated and used in all analyses.
Weight and height were measured to the nearest 0.1 kg
and 0.1 cm, respectively, with the participants wearing
light-weight clothing and without shoes. Body mass
index (BMI) was calculated as the weight in kilograms
divided by the square root of the height in meters.
Fasting blood samples were collected in the morning
after at least 12 h of fasting. Blood samples were ob-
tained from an antecubital vein into Vacutainer tubes
containing ethylenediaminetetraacetic acid (EDTA).
Fasting plasma glucose (FPG), total cholesterol (TC),
low-density lipoprotein cholesterol (LDL-C), high-
density lipoprotein cholesterol (HDL-C), triglycerides
(TGs) and other routine blood biochemical indexes were
analyzed enzymatically using an autoanalyzer. All labora-
tory equipments were calibrated, and blinded duplicate
samples were used for these analyses.
Echocardiographic measurements
Echocardiograms were obtained using a commercially
available Doppler echocardiograph (Vivid, GE Healthcare,
United States), with a 3.0-MHz transducer. The transtho-
racic echocardiogram examinations included M-mode,
two-dimensional, spectral and color Doppler, and were
performed with subjects resting in the supine position.
Echocardiogram analyses and readings were performed by
three doctors specialized in echocardiography. Consulta-
tions were made to two other specialists if any questions
or uncertainty arose. The parasternal acoustic window
was used to record two-dimensional and M-mode images
of the left ventricular (LV) internal diameter, wall thick-
ness, aortic root and left atrium (LA). The apical acoustic
window was used to record 4- and 5-chamber images.
Color Doppler recordings were adopted to identify
valvular regurgitation. The correct orientation of
imaging planes and Doppler recordings were verified
using previously described procedures [11, 12]. The
left ventricular end-diastolic dimension (LVIDd) was
obtained in the LV minor axis at end-diastole, internal
dimensions and interventricular septal thickness
(IVST) and posterior wall thickness (PWT) were mea-
sured at end of the diastole and systole according to
the recommendations of the American Society of
Echocardiography [13, 14]. The LV mass was estimated by
Devereux’s formula 0.8 × [1.04 {(LVIDd + PWT+ SWT)3 −
LVIDd3}] + 0.6 g [15] and normalized to body surface area
(BSA). Left ventricular ejection fraction (LVEF) was mea-
sured from the four-chamber apical projection by the area
product × the ventricular length. Two-dimensional guided
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M-mode measurements of the LA posteroanterior dimen-
sion were performed from the parasternal long-axis view
according to the standards of the American Society of
Echocardiography.
Definitions
Left atrial enlargement was defined as an LA diameter
exceeding 4.0 cm in men and 3.8 cm in women [16].
LAE as the index by body surface area (iLAE) was de-
fined as indexed LA diameter exceeding 2.3 cm/m2 in
both sexes [16]. Higher left ventricular myocardial index
(LVMI) was defined as LVMI exceeding 115 g/m2 in
men and 95 g/m2 in women [16]. According JNC-7 re-
port [17], Hypertension was defined as systolic blood
pressure (SBP) ≥140 mmHg and/or diastolic blood pres-
sure (DBP) ≥90 mmHg and/or use of antihypertensive
medications. BMI were categorized into 2 groups as
normal (BMI <30 kg/m2) and obesity (BMI ≥30 kg/m2),
according to the World Health Organization (WHO)
criteria [18]. Dyslipidemia was defined according to the
National Cholesterol Education Program-Third Adult
Treatment Panel (ATP III) criteria [19]. Diabetes melli-
tus was diagnosed according to the WHO criteria [20]:
FPG ≥ 7 mmol/L (126 mg/dL) and/or being on treatment
for diabetes. Anemia was defined as an hemoglobin con-
centration lower than 110 g/L in women and lower than
120 g/L in men according to the China expert consensus.
Statistical analysis
Descriptive statistics were calculated for all the variables,
including continuous variables (reported as mean values
and standard deviations) and categorical variables (re-
ported as numbers and percentages). The differences
between the LAE and non-LAE groups were evaluated
using the Student’s t-test, analysis of variance, non-
parametric test or the χ2-test, as appropriate. Multivari-
ate logistic regression analyses and linear regression
analysis were used to identify independent factors of
LAE, and odds ratios (ORs). Linear correlation coeffi-
cient β and corresponding 95 % confidence intervals
(CIs) also were calculated. All the statistical analyses
were performed using SPSS version 17.0 software (SPSS
Inc, Chicago, Illinois, USA), and P values less than 0.05
were considered statistically significant.
Results
Background characteristics
Patient baseline characteristics are shown in Table 1. A
total of 10,574 participants (4768 men and 5806 women)
were included in the study. The mean age was 53.81 years.
The subjects in the LAE group were older and included a
higher proportion of women than the non-LAE group
(P < 0.001 for both). Participants with LAE had higher
BP, higher body mass index (BMI), higher prevalence of
diabetes mellitus, higher TG, higher TC, higher LVMI,
lower left ventricular ejection fraction, and lower esti-
mated glomerular filtration rate (eGFR) than those in
the non-LAE group (P < 0.001).
Prevalence of LAE in different sexes and ages
The overall prevalence of LAE was 6.43 % for subjects
aged over 35 years. The prevalence of LAE was 6.78 %
in women and 6.02 % in men. For men, the prevalence
of LAE increased with advancing age (age 35–44 years:
3.32 %; age 45–54 years: 5.31 %; age 55–64 years:
6.95 %; and age ≥65 years: 9.31 %). For women, the
prevalence of LAE was 3.72, 5.03, 9.17, 11.11 %, respect-
ively. As for the total population, the prevalence was
3.55, 5.44, 8.85, 11.37 % respectively (Fig. 1).
After indexed by body surface area, the overall preva-
lence of iLAE was 15.35 % for subjects aged over 35.
The prevalence of iLAE was 20.58 % in female, 9.09 % in
male. For men, the prevalence of LAE increased with
advancing age (age 35–44: 2.3 %; age 45–54: 5.5 %; age
55–64: 11.7 %; age ≥ 65: 20.3 %). As for women, the
prevalence was 9.2, 14.2, 25.6, 44.8 %. As for whole
population, the prevalence was 6.2, 10.3, 19.1, 32.6 %.
Factors associated with LAE
Table 2 shows multivariable logistic regression analysis
of risk factors related to LAE. The prevalence of LAE
was higher for women than men (OR: 1.229, 95 % CI:
1.003–1.507). Advancing age (OR: 1.015, 95 % CI:
1.005–1.026), high systolic blood pressure (SBP) (OR:
2.331, 95 % CI: 1.889–2.876), high diastolic blood pres-
sure (DBP) (OR: 1.24, 95 % CI: 1.016–1.513), high BMI
(OR: 3.956, 95 % CI: 3.208–4.879), high prevalence of
diabetes (OR: 1.498, 95 % CI: 1.19–1.886), high LVMI
(OR: 1.003, 95 % CI: 1.002–1.004), and lower LVEF,
lower heart rate, and lower eGFR were found to be the
major risk factors of LAE. After discussing the associ-
ation between men and women, respectively, no obvious
correlation was found between DBP and LAE. The associ-
ations between diabetes, eGFR and LAE were significant
in men (P < 0.05 vs. P < 0.05), but not in women (P = 0.263
vs. P = 0.751). Additionally, we tested the association by
linear regression analysis (Table 3). Female sex, advancing
age, high SBP, high BMI, high fasting plasma glucose, high
LVMI, low eGFR, low LVEF, and low heart rate were
proven to be highly significant risk factors of LAE.
Additionally, the association between BMI and LAE
was shown to be the most obvious.
Discussion
Our study found that the prevalence of LAE was 6.43 %
in the total population, 6.78 % in women, and 6.02 % in
men. A survey found that the prevalence of LAE defined
according to LA diameter in an urban population in
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Poland was 15.7 %. As for the indexed LA diameter, the
prevalence was 8.8 % [22]. It was found that their partic-
ipants were much older (mean age of 63.0 years) and
obese (mean BMI of 27.9 kg/m2), which may be the
reason for the higher LAE prevalence among them than
in our population. Stritzke et al. reported that the preva-
lence of LAE consists of 9.8 % the German residents [23].
However, they defined LAE as iLA (left atrial volume
indexed in relation to body height) ≥35.7 and ≥33.7 ml/m
in men and women, respectively. Thus, we suspect that
the differences in prevalence between their study and ours
can be attributed to the different population studied,
different age levels, different BMI levels, different BP
levels, and different definitions of LAE. Further, compared
to Europeans and Americans, Asians tend to have smaller,
thinner bodies. Furthermore, our research population was
much larger. Thus, it is understandable that the preva-
lence of LAE in our study was relatively low.
In addition, we also found that the prevalence of LAE
as the index by BSA was higher than that defined by
absolute LA diameter, especially among the women
population. After indexed by body surface area, the
prevalence of iLAE was 15.35 % in total population,
20.58 % in female, and 9.09 % in male. This finding
was different from some studies in Europe and
America [22]. The reason for this difference is that
Asians tend to have smaller, thinner bodies, compared
to Europeans and Americans, especially in elder
women. Their BSA was smaller, so when LAE was de-
fined as LA diameter normalized to BSA >2.3 cm/m2
in both sexes, the prevalence of LAE in Asians became
higher than Europeans and Americans, and the preva-
lence of iLAE was significantly higher in females than
in males. A study in Japan confirmed the results to
Fig. 1 Prevalence of left atrial enlargement in different gender and age
Table 1 Characteristics of the study population
Characteristics Total LAE Non-LAE P
Gender, female 5991 (54.16 %) 406 (57.10 %) 5585 (53.96 %) 0.104
Age, y 53.81 ± 10.52 57.86 ± 10.40 53.53 ± 10.47 <0.001
currentsmoking 3890 (35.17 %) 194 (27.29 %) 3696 (35.71 %) <0.001
Currentdrinking 2476 (22.39 %) 151 (21.24 %) 2325 (22.46 %) 0.448
SBP, mmHg 141.63 ± 23.36 158.18 ± 25.64 140.5 ± 22.76 <0.001
DBP, mmHg 81.97 ± 11.70 86.87 ± 12.52 81.63 ± 11.49 <0.001
HR, beats minute 71.66 ± 12.3 71.03 ± 11.90 71.70 ± 12.33 0.165
BMI, Kg/m2 24.78 ± 3.66 27.54 ± 3.77 24.60 ± 3.58 <0.001
Diabetes mellitus 1148 (10.38 %) 133 (18.71 %) 1015 (9.81 %) <0.001
HDL-C, mol/L 1.41 ± 0.38 1.32 ± 0.32 1.41 ± 0.38 <0.001
LDL-C, mol/L 2.93 ± 0.82 3.08 ± 0.85 2.92 ± 0.82 <0.001
TG, mmol/L 1.63 ± 1.47 1.89 ± 1.42 1.62 ± 1.48 <0.001
TC, mmol/L 5.24 ± 1.09 5.38 ± 1.11 5.23 ± 1.08 <0.001
eGFR, mL/min/1.73 m2 92.81 ± 15.87 88.02 ± 18.51 93.14 ± 15.62 <0.001
Hemoglobin, g/L 138.6 ± 18.74 138.28 ± 24.50 138.63 ± 18.29 0.638
LVDd, cm 4.71 ± 0.43 5.07 ± 0.55 4.68 ± 0.41 <0.001
IVST, cm 0.89 ± 0.26 1.01 ± 0.38 0.88 ± 0.24 <0.001
PWT, cm 0.87 ± 0.26 0.96 ± 0.36 0.86 ± 0.25 <0.001
LVMI, g/m2 86.83 ± 59.31 110.44 ± 87.80 85.21 ± 56.48 <0.001
LVEF, % 62.97 ± 3.81 61.33 ± 4.77 63.09 ± 3.71 <0.001
E/A 1.06 ± 4.28 0.91 ± 0.74 1.07 ± 4.42 0.339
Abbreviations: LAE left atrial enlargement, Non-LAE non-left atrial enlargement, BMI body mass index, SBP systolic blood pressure, DBP diastolic blood pressure, TC
total cholesterol, TG triglycerides, LDL-C low density lipoprotein cholesterol, HDL-C high density lipoprotein cholesterol, eGFR glomerular filtration rate, HR heart
rate, LVDd left ventricular end-diastolic dimension, IVST interventricular septal thickness, PWT posterior wall thickness, LVEF left ventricular ejection fraction
Note: data are expressed as mean ± standard deviation or n (%)
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some extent [24]: Although the LA volume was similar
between males and females, the LA volume indexed by
BSA was significantly higher in females than in males.
Our study results indicated that advancing age and
female sex were significantly associated with LAE, which
has been reported in previous studies [9, 25]. In the case
of advancing age, there are a few possible causes: valvular
degeneration, cardiac systolic or diastolic dysfunction,
hypertension among other factors. Compared to men, the
higher prevalence of LAE in women may be ascribed to
several factors, including higher systolic (143.4 vs.
139.9 mmHg) and mean arterial pressure (103.5 vs.
Table 2 Multivariable logistic regression analysis of risk factors related to left atrial enlargement
Characteristics Total Male Female
OR (95 % CI) P OR (95 % CI) P OR (95 % CI) P
Gender, female 1.229 (1.003–1.507) 0.046
Age 1.015 (1.005–1.026) 0.005 1.007 (0.992–1.022) 0.383 1.017 (1.002–1.032) 0.026
Current smoking 0.741 (0.607–0.905) 0.003 0.741 (0.570–0.963) 0.025 0.730 (0.533–0.998) 0.049
Current drinking 1.274 (1.001–1.62) 0.048 1.291 (0.987–1.688) 0.063 1.308 (0.715–2.393) 0.384
SBP ≥ 140 2.331 (1.889–2.876) 0.000 2.673 (1.901–3.758) 0.000 2.033 (1.551–2.664) 0.000
DBP ≥ 80 1.24 (1.016–1.513) 0.034 1.302 (0.966–1.754) 0.083 1.161 (0.888–1.518) 0.276
HR 0.980 (0.972–0.987) 0.000 0.979 (0.967–0.990) 0.0002 0.978 (0.968–0.988) 0.000
BMI ≥ 30 3.956 (3.208–4.879) 0.000 4.947 (3.53–6.932) 0.000 3.414 (2.61–4.467) 0.000
Diabetes mellitus 1.498 (1.19–1.886) 0.0005 2.042 (1.443–2.889) 0.000 1.192 (0.877–1.518) 0.263
TC 0.953 (0.880–1.033) 0.242 0.977 (0.860–1.11) 0.720 0.931 (0.839–1.033) 0.176
TG 1.029 (0.977–1.083) 0.277 0.973 (0.899–1.054) 0.507 1.076 (1.002–1.154) 0.043
eGFR, 0.991 (0.985–0.997) 0.004 0.979 (0.969–0.989) 0.000 0.999 (0.991–1.007) 0.751
Anemia 1.253 (0.981–1.6) 0.07 1.222 (0.771–1.938) 0.394 1.326 (0.990–1.774) 0.058
LVMI 1.003 (1.002–1.004) 0.000 1.002 (1.000–1.003) 0.009 1.004 (1.003–1.006) 0.000
LVEF 0.928 (0.911–0.946) 0.000 0.939 (0.913–0.966) 0.000 0.919 (0.896–0.942) 0.000
E/A 0.892 (0.703–1.133) 0.350 1.017 (0.934–1.107) 0.695 0.523 (0.348–0.788) 0.002
Table 3 Linear regression analysis of risk factors related to left atrial enlargement
Characteristics Total Male Female
β (95 % CI) P β (95 % CI) P β (95 % CI) P
Gender, female 0.197 (−0.174, −0.139) 0.000
Age 0.036 (0.0005, 0.002) 0.002 0.017 (−0.0006, 0.002) 0.335 0.049 (0.0005, 0.003) 0.006
Current smoking 0.001 (−0.015, 0.016) 0.897 0.001 (−0.020, 0.021) 0.945 −0.002 (−0.027, 0.023) 0.873
Current drinking 0.030 (0.009, 0.047) 0.003 0.037 (0.008, 0.049) 0.006 −0.001 (−0.056, 0.052) 0.951
Mean SBP 0.185 (0.003, 0.004) 0.185 0.176 (0.002, 0.003) 0.000 0.194 (0.003, 0.004) 0.000
Mean DBP −0.045 (−0.002, −0.0006) 0.034 −0.018 (−0.002, 0.001) 0.373 −0.066 (−0.003, −0.001) 0.0002
HR −0.122 (−0.005, −0.003) 0.000 −0.138 (−0.005, −0.004) 0.000 −0.119 (−0.005, −0.003) 0.000
BMI 0.373 (0.038, 0.042) 0.000 0.380 (0.038, 0.044) 0.000 0.378 (0.037, 0.042) 0.000
FPG 0.030 (0.003, 0.012) 0.0005 0.037 (0.002, 0.015) 0.000 0.026 (0.0004, 0.012) 0.263
TC −0.019 (−0.014, −0.0004) 0.038 −0.007 (−0.012, −0.008) 0.641 −0.036 (−0.021, −0.003) 0.006
TG 0.014 (−0.001, 0.008) 0.146 −0.011 (−0.009, −0.004) 0.434 0.032 (0.002, 0.017) 0.012
eGFR −0.029 (−0.001, −0.0002) 0.005 −0.050 (−0.002, −0.0005) 0.001 −0.009 (−0.0009, 0.0005) 0.540
Hemoglobin −0.059 (−0.002, −0.0008) 0.000 −0.038 (−0.001, −0.0002) 0.005 1.326 (0.990–1.774) 0.058
LVMI 0.073 (0.0004, 0.0007) 0.000 0.075 (0.0003, 0.0006) 0.000 0.076 (0.0005, 0.0009) 0.000
LVEF −0.038 (−0.006, −0.002) 0.000 −0.013 (−0.004, 0.001) 0.332 −0.059 (−0.008, −0.004) 0.000
E/A −0.007 (−0.009, 0.003) 0.392 −0.002 (−0.007, 0.006) 0.897 −0.039 (−0.063, −0.011) 0.005
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100.3 mmHg), and higher LVMI (91.85 vs. 81.77 g/m2),
among other factors.
In our research, high SBP was significantly associated
with LAE in different adjusted models. After adjusting
for sex, DBP was not found to have an obvious correl-
ation with LAE, which was consistent with many other
studies [23]. Stritzke et al. found that LA pressure load
in hypertensive individuals resulted in an increase in LA
size [23]. Additionally, the association between BMI and
LAE was shown to be the most obvious in our study,
which was consistent with many other studies [9, 23].
Especially, Stritzke et al. reported that obesity appears
to be the most important risk factor for LAE in the
general population [23]. We also found an important
result: diabetes and lower eGFR were positively associated
with LAE in the general population, which was also
consistent with previous studies [27, 28]. However, in our
study, the association between diabetes, eGFR and LAE
was only observed in men but not in women, after adjust-
ing for sex.
Actually, previous studies confirmed that higher LVMI
was associated with left atrial size [26, 27]. Our study
further validates that affirmation. Appleton et al. showed
that increased LVMI was related to increased LV stiffness
and increase in LV filling pressure, which leads to LA
enlargement [25]. Furthermore, our finding that heart rate
was inversely related to LAE was consistent with previous
studies [26, 28].
Limitations
The present study had several limitations. First, our study
was a cross-sectional study, which restricted the interpret-
ation of the observed associations in terms of causality.
Second, recent studies have shown that LA volume may
be more accurate for the definition of LAE than LA diam-
eter; therefore, the lack of LA volume data is a limitation
of this study. However, the simple linear measurement is
more common and convenient in daily clinical practice.
Additionally, we consider that LA diameter is still helpful
in identifying high-risk individuals.
Conclusion
Our population-based study indicated that the latest
prevalence of LAE in rural areas of China is not as high
as that in European and American countries. The preva-
lence was similar between males and females, overall the
women was slightly higher. After indexed by BSA, the
prevalence of iLAE became higher, and it was significantly
higher in females than in males. Female sex, advancing
age, high SBP, higher BMI, diabetes, higher LVMI, lower
eGFR, lower LVEF, and lower HR were found to be risk
factors of LAE. Further prospective studies are required to
verify these findings.
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